Interestingly, the ATG16L1 T300A variant, a major CD susceptibility allele, has been shown to be associated with the development of gastric cancer susceptibility [45], and is also associated with increased overall survival and tumor apoptosis as well as inhibition of EGFR and PPAR pathways in gastric cancer [46]. This evidence concerns the gene EGFR and neoplasm.